20年全国随访研究:首发精神分裂症停药与治疗失败风险
该研究基于芬兰1996-2014年全国登记数据,纳入8719例首次因精神分裂症住院的患者,评估停用抗精神病药后治疗失败(再住院或死亡)的风险。结果显示,持续用药者风险最低,停药后治疗失败风险随时间推移不降反升,且早期停药者死亡风险更高。
要点
- 持续使用抗精神病药者再住院或死亡风险最低。
- 停药后治疗失败风险不随时间推移而降低,反而升高。
- 早期停药者死亡风险较持续用药者高174%-214%。
核心结论
- 停药后治疗失败或复发风险在疾病前8年并不随时间推移而降低。
- 长期抗精神病药治疗与生存率提高相关。
研究设计与样本
- 基于芬兰全国登记数据库的前瞻性队列研究,纳入1996-2014年首次因精神分裂症住院的全部患者(N=8,719)。
- 采用多变量Cox回归评估停药后治疗失败(精神科再住院或死亡)的风险。
主要发现
- 持续用药者再住院或死亡风险最低(调整后风险比=1.00)。
- 出院后立即停药者风险比=1.63(95%CI=1.52-1.75)。
- 1年内停药者风险比=1.88(95%CI=1.57-2.24)。
- 1-2年内停药者风险比=2.12(95%CI=1.43-3.14)。
- 2-5年内停药者风险比=3.26(95%CI=2.07-5.13),5年后停药者风险比=7.28(95%CI=2.78-19.05)。
关键数值与推荐
- 持续用药者(最长16.4年)为参照组,调整后风险比=1.00。
- 非用药者及早期停药者死亡风险较持续用药者高174%-214%。
临床怎么用
- 首发精神分裂症稳定后不应常规建议短期用药后停药,长期维持治疗可能改善生存。
- 停药决策需权衡复发风险与死亡风险,尤其避免早期停药。
局限性
- 观察性登记数据,无法完全排除混杂因素。
- 治疗失败定义限于再住院或死亡,未涵盖其他临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: It is generally believed that after the first episode of schizophrenia, the risk of relapse decreases with time in patients who are stabilized. Many treatment guidelines recommend that after stabilization, antipsychotic treatment should be continued for 1-5 years, and longer exposure should be avoided if possible. However, there is no published evidence to substantiate this view. The authors used nationwide databases to investigate this issue. METHOD: Prospectively gathered nationwide register data were used to study the risk of treatment failure (psychiatric rehospitalization or death) after discontinuation of antipsychotic treatment. Multivariate Cox regression was used to assess outcomes among all patients hospitalized for the first time with a schizophrenia diagnosis in Finland during the period of 1996-2014 (N=8,719). RESULTS: The lowest risk of rehospitalization or death was observed for patients who received antipsychotic treatment continuously (adjusted hazard ratio=1.00), followed by patients who discontinued antipsychotic use immediately after discharge from the first hospital treatment (hazard ratio=1.63, 95% CI=1.52-1.75), within 1 year (hazard ratio=1.88, 95% CI=1.57-2.24), within 1-2 years (hazard ratio=2.12, 95% CI=1.43-3.14), within 2-5 years (hazard ratio=3.26, 95% CI=2.07-5.13), and after 5 years (a median of 7.9 years) (hazard ratio=7.28, 95% CI=2.78-19.05). Risk of death was 174%-214% higher among nonusers and patients with early discontinuation of antipsychotics compared with patients who received antipsychotic treatment continuously for up to 16.4 years. CONCLUSIONS: Whatever the underlying mechanisms, these results provide evidence that, contrary to general belief, the risk of treatment failure or relapse after discontinuation of antipsychotic use does not decrease as a function of time during the first 8 years of illness, and that long-term antipsychotic treatment is associated with increased survival.
引用
- Tiihonen J, Tanskanen A, Taipale H, et al. 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. Am J Psychiatry. 2018. PMID: 29621900. doi:10.1176/appi.ajp.2018.17091001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。